MENU
CNTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Context Therapeutics (CNTX) Earnings Date & Reports
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors... Show more
A.I. Advisor
published Earnings
CNTX is expected to report earnings to rise 9.11% to -9 cents per share on November 11
Q3'26
Est.
$-0.10
Q1'26
Beat
by $0.02
Q4'25
Missed
by $0.04
Q3'25
Missed
by $0.01
Q2'25
Missed
by $0.03
The last earnings report on May 06 showed earnings per share of -9 cents, beating the estimate of -11 cents. With 785.27K shares outstanding, the current market capitalization sits at 46.55M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Details
Industry
N/A
Address
2001 Market Street
Phone
+1 267 225-7416
Employees
15
Web
https://www.contexttherapeutics.com